Trial · NCT07891845
Comparison of Two Surgical Techniques for Indirect Inguinal Hernia Repair
NCT07891845, Not applicable, Recruiting, Hitit University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of Two Surgical Techniques for Indirect Inguinal Hernia Repair. Trials, record NCT07891845. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891845
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of Two Surgical Techniques for Indirect Inguinal Hernia Repair
- NCT number
- NCT07891845
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 90 participants, estimated
- Lead sponsor
- Hitit University
- Conditions
- Indirect Inguinal Hernia
- Interventions
- Standard TAPP Repair With Complete Hernia Sac Dissection, TAPP Repair With Primary Abandon of the Sac
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of Participants With Seroma at Postoperative Day 30 | Postoperative Day 30 | Percentage of participants with a seroma in the operated inguinal or scrotal region at postoperative day 30. Seroma is defined as a fluctuant fluid collection detected on physical examination and/or a fluid collection demonstrated by ultrasonography. Ultrasonography will be performed when examination findings are uncertain or a seroma is clinically suspected. Seroma rates will be compared between groups to assess non-inferiority of PAS using an absolute margin of 15 percentage points. |
| Other | Operative Time | Intraoperative period, from skin incision to skin closure | Duration of surgery in minutes, measured from the first skin incision to final skin closure. |
| Other | Postoperative Pain Score | Postoperative Days 1 and 7, and Months 1, 6, and 12 | Pain intensity measured on a 0-10 visual analog scale or numeric rating scale, where 0 indicates no pain and 10 indicates the worst imaginable pain. |
| Other | Hernia-Related Quality of Life | Baseline and Postoperative Months 1, 6, and 12 | Hernia-related quality of life assessed using the EuraHS-QoL questionnaire, covering pain, activity restriction, and cosmetic discomfort. Higher scores indicate worse quality of life. Postoperative scores will be compared between groups and with baseline values. |
| Other | Length of Hospital Stay | From surgery to hospital discharge, an average of 1 day | Duration of hospitalization in days following hernia repair, measured from surgery to discharge. |
| Other | Time to Return to Normal Daily Activities | From surgery through postoperative Month 12 | Number of days from surgery until the participant can independently perform basic daily activities without a marked increase in analgesic requirements. |
| Other | Postoperative Complications | Through postoperative Month 12 | Percentage of participants experiencing postoperative complications. Complications will be graded according to the Clavien-Dindo classification. |
| Other | Postoperative Hematoma | Through postoperative Month 12 | Percentage of participants with a hematoma in the operated inguinal or scrotal region. |
| Other | Postoperative Hydrocele | Through postoperative Month 12 | Percentage of participants with a postoperative hydrocele on the operated side. |
| Other | Postoperative Scrotal Edema | Through postoperative Month 12 | Percentage of participants with postoperative scrotal edema. |
1 to 10 of 17Source ClinicalTrials.gov
See all 17 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07891845
GET https://conductscience.org/api/trials/v1/NCT07891845/registered